About Generable
Generable is a company based in New York (United States) founded in 2016 by Eric Novik and Daniel Lee. Generable has raised $120 thousand across 1 funding round from investors including Techstars. Generable offers products and services including Joint Outcome-Biomarker Models, Complex PK/PD Models, and Biomarker Screening Models. Generable operates in a competitive market with competitors including InSilicoTrials, CONTINUUM India, Cognigen, Pharmetheus and Chrestos, among others.
- Headquarter New York, United States
- Founders Eric Novik, Daniel Lee
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Generable Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$120 K (USD)
in 1 rounds
-
Latest Funding Round
$120 K (USD), Seed
Jun 01, 2017
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Generable
Generable offers a comprehensive portfolio of products and services, including Joint Outcome-Biomarker Models, Complex PK/PD Models, and Biomarker Screening Models.
Links hazards with biomarkers for accurate health predictions.
Simulates drug behavior using ODE solvers for pharmacokinetics.
Provides predictions with uncertainties for biomarker evaluation.
People of Generable
Unlock access to complete
Unlock access to complete
Stan Team
1 people
Advisor Team
1 people
Leadership Team
1 people
Data Analysis and Operations Team
1 people
Unlock access to complete
Funding Insights of Generable
Generable has successfully raised a total of $120K through 1 strategic funding round. The most recent funding activity was a Seed round of $120 thousand completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Generable
Generable has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Techstars.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups are accelerated globally without sector restrictions through structured programs.
|
Locked | Locked | Locked |
Investor details for Generable
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Generable
Investment portfolio details for Generable
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Generable
Detailed financials for Generable
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Generable Comparisons
Peer comparison for Generable
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Generable
Generable operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as InSilicoTrials, CONTINUUM India, Cognigen, Pharmetheus and Chrestos, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Healthcare simulation services are provided for medical applications worldwide.
|
|
| Locked | Locked | Locked |
Offers pharmacovigilance, regulatory, evidence evaluation, and technology solutions to pharma firms.
|
|
| Locked | Locked | Locked |
Strategic clinical pharmacology and pharmacometric consulting services are provided.
|
|
| Locked | Locked | Locked |
Offers pharmacometric services to support efficient and effective drug development processes.
|
|
| Locked | Locked | Locked |
Pharmacokinetic and pharmacodynamic study services are offered by this CRO.
|
Detailed competitors of Generable
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Generable
Complete news archive for Generable
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Generable
Generable was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Generable is headquartered in New York, United States. It is registered at New York, New York, United States.
Eric Novik is the current CEO of Generable. They have also founded this company.
Generable is a funded company, having raised a total of $120K across 1 funding round to date.
Generable was founded in 2016 in New York, United States, within the precision medicine sector. Statistical machine learning is utilized to develop models for preclinical and clinical drug development, including Bayesian computing approaches. Focus is placed on neuroscience, immuno-oncology, rare diseases, and personalized decision-making, with pharmacometrics, genomic, and brain network models employed. Services are provided to clients such as Sanofi and AstraZeneca.
Generable's top competitors include InSilicoTrials, Chrestos and Incite Health.
Generable offers Joint Outcome-Biomarker Models, Complex PK/PD Models, and Biomarker Screening Models.
Generable has 1 investor. Key investors include Techstars.